全文获取类型
收费全文 | 4682篇 |
免费 | 330篇 |
国内免费 | 28篇 |
专业分类
耳鼻咽喉 | 75篇 |
儿科学 | 114篇 |
妇产科学 | 152篇 |
基础医学 | 614篇 |
口腔科学 | 208篇 |
临床医学 | 441篇 |
内科学 | 834篇 |
皮肤病学 | 162篇 |
神经病学 | 215篇 |
特种医学 | 144篇 |
外科学 | 831篇 |
综合类 | 78篇 |
一般理论 | 3篇 |
预防医学 | 330篇 |
眼科学 | 87篇 |
药学 | 479篇 |
中国医学 | 34篇 |
肿瘤学 | 239篇 |
出版年
2023年 | 41篇 |
2022年 | 45篇 |
2021年 | 156篇 |
2020年 | 131篇 |
2019年 | 186篇 |
2018年 | 226篇 |
2017年 | 177篇 |
2016年 | 183篇 |
2015年 | 200篇 |
2014年 | 280篇 |
2013年 | 322篇 |
2012年 | 439篇 |
2011年 | 435篇 |
2010年 | 251篇 |
2009年 | 192篇 |
2008年 | 264篇 |
2007年 | 232篇 |
2006年 | 211篇 |
2005年 | 191篇 |
2004年 | 150篇 |
2003年 | 136篇 |
2002年 | 113篇 |
2001年 | 39篇 |
2000年 | 41篇 |
1999年 | 34篇 |
1998年 | 20篇 |
1997年 | 13篇 |
1996年 | 24篇 |
1995年 | 20篇 |
1994年 | 15篇 |
1993年 | 18篇 |
1992年 | 17篇 |
1991年 | 22篇 |
1990年 | 24篇 |
1989年 | 19篇 |
1988年 | 14篇 |
1987年 | 27篇 |
1986年 | 24篇 |
1985年 | 13篇 |
1984年 | 8篇 |
1983年 | 10篇 |
1982年 | 9篇 |
1981年 | 8篇 |
1980年 | 12篇 |
1979年 | 6篇 |
1978年 | 5篇 |
1972年 | 4篇 |
1971年 | 8篇 |
1970年 | 4篇 |
1966年 | 4篇 |
排序方式: 共有5040条查询结果,搜索用时 17 毫秒
11.
12.
13.
Abdulqader Abbas Ahmed Ren Liling Alhammadi Maged Abdu Zainab Abdulkader Mohamed Abdo Ahmed Saleh 《Oral Radiology》2020,36(4):371-382
Oral Radiology - This study aimed to analyze the detailed three-dimensional measurements of temporomandibular joint (TMJ) in Chinese adults with normal occlusion and harmonious skeleton. In 51... 相似文献
14.
Subcutaneous immunization with a novel immunogenic candidate (urease) confers protection against Brucella abortus and Brucella melitensis infections 下载免费PDF全文
Morteza Abkar Jafar Amani Abbas Sahebghadam Lotfi Gholamreza Nikbakht Brujeni Saeed Alamian Mehdi Kamali 《APMIS : acta pathologica, microbiologica, et immunologica Scandinavica》2015,123(8):667-675
Brucellosis is a world prevalent endemic illness that is transmitted from domestic animals to humans. Brucella spp. exploits urease for survival in the harsh conditions of stomach during the gastrointestinal infection. In this study, we examined the immune response and the protection elicited by using recombinant Brucella urease (rUrease) vaccination in BALB/c mice. The urease gene was cloned in pET28a and the resulting recombinant protein was employed as subunit vaccine. Recombinant protein was administered subcutaneously and intraperitoneally. Dosage reduction was observed with subcutaneous (SC) vaccination when compared with intraperitoneal (IP) vaccination. rUrease induced mixed Th1–Th2 immune responses with high titers of specific IgG1 and IgG2a. In lymphocyte proliferation assay, splenocytes from IP and SC‐vaccinated mice displayed a strong recall proliferative response with high amounts of IL‐4, IL‐12 and IFN‐γ production. Vaccinated mice were challenged with virulent Brucella melitensis, B. abortus and B. suis. The SC vaccination route exhibited a higher degree of protection than IP vaccination (p value ≤ 0.05). Altogether, our results indicated that rUrease could be a useful antigen candidate for the development of subunit vaccines against brucellosis. 相似文献
15.
16.
17.
18.
Nohra Ghaoui MD Edith Hanna MD Ossama Abbas MD Abdul-Ghani Kibbi MD Mazen Kurban MD 《International journal of dermatology》2020,59(7):787-795
Dapsone (4,4'-diaminodiphenylsulfone) is the only remaining sulfone used in anthropoid therapeutics and is commercially available as an oral formulation, an inhaled preparation, and a 5% or 7.5% cream. Dapsone has antimicrobial effects stemming from its sulfonamide-like ability to inhibit the synthesis of dihydrofolic acid. It also has anti-inflammatory properties such as inhibiting the production of reactive oxygen species, reducing the effect of eosinophil peroxidase on mast cells and down-regulating neutrophil-mediated inflammatory responses. This allows for its use in the treatment of a wide variety of inflammatory and infectious skin conditions. Currently in dermatology, the US Food and Drug Administration (FDA)-approved indications for dapsone are leprosy, dermatitis herpetiformis, and acne vulgaris. However, it proved itself as an adjunctive therapeutic agent to many other skin disorders. In this review, we discuss existing evidence on the mechanisms of action of dapsone, its FDA-approved indications, off-label uses, and side effects. 相似文献
19.
Ramona Meister Mariam Abbas Jochen Antel Triinu Peters Yiqi Pan Ulrike Bingel Yvonne Nestoriuc Johannes Hebebrand 《European child & adolescent psychiatry》2020,29(3):253-273
Children and adolescents with major depressive disorder (MDD) appear to be more responsive to placebo than adults in randomized placebo-controlled trials (RCTs) of second and newer generation antidepressants (SNG-AD). Previous meta-analyses obtained conflicting results regarding modifiers. We aimed to conduct a meta-analytical evaluation of placebo response rates based on both clinician-rating and self-rating scales. Based on the most recent and comprehensive study on adult data, we tested whether the placebo response rates in children and adolescents with MDD also increase with study duration and number of study sites. We searched systematically for published RCTs of SNG-AD in children and/or adolescents (last update: September 2017) in public domain electronic databases and additionally for documented studies in clinical trial databases. The log-transformed odds of placebo response were meta-analytically analyzed. The primary and secondary outcomes were placebo response rates at the end of treatment based on clinician-rating and self-rating scales, respectively. To examine the impact of study duration and number of study sites on placebo response rates, we performed simple meta-regression analyses. We selected other potential modifiers of placebo response based on significance in at least one previous pediatric meta-analysis and on theoretical considerations to perform explorative analyses. We applied sensitivity analyses with placebo response rates closest to week 8 to compare our data with those reported for adults. We identified 24 placebo-controlled trials (2229 patients in the placebo arms). The clinician-rated placebo response rates ranged from 22 to 62% with a pooled response rate of 45% (95% CI 41–50%). The number of study sites was a significant modifier in the simple meta-regression analysis [odds ratio (OR) 1.01, 95% CI 1.01–1.02, p = 0.0003, k = 24) with more study sites linked to a higher placebo response. Study duration was not significantly associated with the placebo response rate. The explorative simple analyses revealed that publication year may be an additional modifier. However, in the explorative multivariable analysis including the number of study sites and the publication year only the number of study sites reached a p value ≤ 0.05. The self-rated placebo response rates ranged from 1 to 68% with a pooled response rate of 26% (95% CI 10–54%) (k = 6; n = 396). This meta-analysis confirms a high pooled placebo response rate in children and adolescents based on clinician ratings, which exceeds that observed in the most recent meta-analysis of placebo effects in adults (36%; 95% CI 35–37%) published in 2016. However, and similar to findings in adults, the pooled response rates based on self-ratings were substantially lower. In accordance with previous meta-analyses, we corroborated the number of study sites as significant modifier. In comparison to the recent adult meta-analysis, the substantially lower number of pediatric studies entails a reduced power to detect modifiers. Future studies should provide more precise and homogenous information to support discovery of potential modifiers and consider no-treatment—if ethically permissible—to allow differentiation between placebo and spontaneous remission rates. If these differ, practicing clinicians should facilitate placebo effects as an addition to the verum effect to maximize benefits. Further research is required to explain the discrepant response rates between clinician and self-ratings. 相似文献
20.